In ER+ breast cancers, high p73 levels were borderline non-significant for shorter BCSS (p= 0.056) (Figure 1J) and non-significant in ER- breast cancers (p = 0.599) (Figure 1K). The gene discussed is TP73; the disease is breast cancer.